Clinical profile, therapeutic approach and outcome of gouty arthritis in northern India.
Thirty patients with gouty arthritis were studied over 3 years. The diagnosis was established with the help of polarised light microscopy. All the patients were males, with a median age of 45 years. They belonged to the middle or upper socio-economic class and were obese (mean body mass index 29.7). Chronic alcoholism, diabetes mellitus and hypertension were present in one patient each. No patient had symptomatic coronary artery disease. Although 6 patients had a history of renal colic, only one had gouty nephropathy with chronic renal failure. Six patients had a positive family history of gout. The disease involved mostly the joints of the lower extremity and podagra was observed in 70% of patients. Eight patients had tophi at various sites. There were 17 'over producers' and 13 'under excretors' of uric acid. The treatment consisted of patient education, symptomatic control with non steroidal anti-inflammatory drugs and/or colchicine and antihyperuricaemic therapy. The overproducers were treated with allopurinol while the under excretors were treated with [corrected] sulfinpyrazone. In general, there was a good response to therapy as indicated by lowering of serum uric acid and the number of painful episodes per year. The overall profile of the disease appears similar to that seen in the West.
Kumar
A
A
Department of Medicine, All India Institute of Medical Sciences, New Delhi.
Singh
Y N
YN
Malaviya
A N
AN
Chaudhary
K
K
Tripathy
S
S
D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015210:Arthritis, Gouty / Q000097:blood / Q000473:pathology* / Q000652:urine; D005069:Evaluation Studies as Topic; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood / Q000652:urine
D000894:Anti-Inflammatory Agents, Non-Steroidal; D014527:Uric Acid; D000493:Allopurinol; D013442:Sulfinpyrazone